Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Sues FDA On Crestor Generics: Fighting A 'Foregone Conclusion'?

This article was originally published in The Pink Sheet Daily

Executive Summary

Company is waging the same legal battle Otsuka lost last year, arguing pediatric orphan indication should block approvals of ANDAs.

Advertisement

Related Content

FDA Nixes Innovator Industry-Backed Changes To Citizen Petition Rule
Crestor Generics To Launch After 12-Day Delay
Crestor Generics On Hold As FDA, AstraZeneca Talk About Exclusivity
Crestor Discounting Keeps Allergan's Generic Off UnitedHealth Formulary
Generic Crestor Marks The End Of An Era, Should Quickly Outperform PCSK9s
Glucophage Generics Enter Market: Bristol Says It Will Not Sue Agency

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS079554

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel